このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Fear of Childbirth and Its Association With Mode of Delivery, Labor Pain, and Epidural Analgesia Request in First-Time Mothers (FOC-LABOR)

2026年11月12日 更新者:Ayşenur Türe、Ankara City Hospital Bilkent

Association of Fear of Childbirth Level, Measured by the Wijma Delivery Expectancy/Experience Questionnaire Version A (W-DEQ-A), With Mode of Delivery, Labor Pain, and Epidural Analgesia Request in Nulliparous Term Pregnant Women: A Prospective Observational Study

The goal of this observational study is to learn whether the level of fear of childbirth before active labor is related to how the baby is born, how intense labor pain is, and whether epidural pain relief is requested, in first-time mothers with a full-term pregnancy who plan a vaginal birth.

The main questions it aims to answer are:

  • Do women with severe fear of childbirth have a higher rate of unplanned (emergency) cesarean delivery?
  • Do women with more fear of childbirth feel more intense labor pain?
  • Do women with more fear of childbirth ask for an epidural more often, and earlier in labor?

Researchers will compare women with severe fear of childbirth (a score of 85 or higher on the Wijma Delivery Expectancy/Experience Questionnaire, version A, or W-DEQ-A) with women whose scores are below 85.

Participants will:

  • Fill out the Turkish version of the W-DEQ-A, a 33-item questionnaire about thoughts and feelings regarding the coming birth. It is completed once after admission to the labor ward, before active labor and before any pain relief, and takes about 10 to 15 minutes.
  • Rate their labor pain on a scale from 0 (no pain) to 10 (worst imaginable pain) during active labor and, if they ask for an epidural, at the time of the request.
  • Receive routine labor care. The study does not change any treatment or clinical decision; information on labor, pain relief and delivery will be collected from hospital records.

The study will take place at Ankara Bilkent City Hospital in Ankara, Türkiye.

調査の概要

詳細な説明

BACKGROUND

Fear of childbirth (FOC) is common in pregnancy. A systematic review and meta-analysis of 29 studies including 853,988 pregnant women estimated the worldwide pooled prevalence of tocophobia at 14% (95% confidence interval 12-16%). Previous studies have linked FOC to requests for cesarean delivery without a medical indication, longer labor, greater use of epidural analgesia and a more negative birth experience. Evidence on whether fear measured before active labor predicts intrapartum outcomes in nulliparous women who plan a vaginal birth is inconsistent, and prospective data from Türkiye, which has the highest cesarean delivery rate among OECD countries, are limited.

The Wijma Delivery Expectancy/Experience Questionnaire (W-DEQ) is the most widely used instrument for measuring FOC. Version A (W-DEQ-A) assesses a woman's expectations of the coming birth during pregnancy. It consists of 33 items rated on a 6-point Likert scale (0-5), giving a total score from 0 to 165; higher scores indicate greater fear, and a score of 85 or higher is commonly used to define severe FOC. The Turkish version of the W-DEQ-A has been validated in pregnant women (Cronbach's alpha 0.89).

OBJECTIVES

Primary objective: to determine whether severe FOC (W-DEQ-A score of 85 or higher), measured before active labor, is associated with intrapartum (unplanned) cesarean delivery in nulliparous women with a term singleton pregnancy who plan a vaginal birth.

Secondary objectives: to assess the association of FOC, analyzed both as a continuous W-DEQ-A score and as a dichotomous group, with (1) mode of delivery, (2) labor pain intensity, and (3) the request for epidural labor analgesia and the cervical dilatation at which it is requested.

Exploratory objectives: to describe the duration of the active first stage and second stage of labor and the indications for intrapartum cesarean delivery according to FOC level.

DESIGN AND SETTING

This is a single-center, prospective observational cohort study conducted in the labor and delivery unit of the Department of Obstetrics and Gynecology, Ankara Bilkent City Hospital, a tertiary referral center in Ankara, Türkiye. The investigators do not assign any intervention. Labor management, induction, analgesia and decisions on operative delivery follow routine institutional practice and are made by the attending clinical team. W-DEQ-A scores will not be shared with the team managing labor, so that clinical decisions are not influenced by the study.

PARTICIPANTS AND PROCEDURES

Nulliparous women aged 18 to 45 years with a singleton, cephalic, term pregnancy (37+0 to 41+6 weeks) who are admitted for planned vaginal birth, either in the latent phase of spontaneous labor or for induction of labor, will be screened consecutively. After written informed consent, and before active labor (cervical dilatation less than 5 cm) and before any analgesia, participants will complete the Turkish W-DEQ-A in a quiet setting. Sociodemographic and obstetric characteristics will be recorded on a standardized data collection form that contains no names or national identity numbers. Labor, delivery and neonatal data will be collected prospectively by the research team and verified against medical records until discharge.

EXPOSURE

The exposure is the W-DEQ-A total score, analyzed as a continuous variable (per 10-point increase) and dichotomized at 85 (severe FOC versus non-severe FOC).

OUTCOME ASSESSMENT

  • Mode of delivery: spontaneous vaginal, operative vaginal (vacuum or forceps) or intrapartum cesarean delivery, with the primary indication for cesarean delivery.
  • Labor pain: 10-cm visual analogue scale (VAS; 0 = no pain, 10 = worst imaginable pain) at the first vaginal examination showing cervical dilatation of 5 cm or more before any analgesia, and at the time of an epidural request before the block is placed.
  • Epidural analgesia: whether the participant requests epidural analgesia, the time and cervical dilatation at the request, and whether the epidural is placed.
  • Labor characteristics: onset of labor (spontaneous or induced), oxytocin augmentation, duration of the active first stage and second stage of labor, birth weight and Apgar scores.

COVARIATES

Prespecified potential confounders are maternal age, body mass index, education level, gestational age, attendance at antenatal education classes, onset of labor (spontaneous or induced) and birth weight. Epidural analgesia and oxytocin augmentation lie on the possible causal pathway between FOC and mode of delivery; they will be examined as mediators in sensitivity analyses rather than adjusted for in the main model.

SAMPLE SIZE

Assuming an intrapartum cesarean rate of 25% among women with a W-DEQ-A score below 85 and a 20% prevalence of severe FOC (group ratio 1:4), 460 women (92 with severe FOC and 368 without) are needed to detect an increase in the cesarean rate to 40% (relative risk 1.6; odds ratio 2.0) with 80% power and a two-sided alpha of 0.05. To allow for about 10% incomplete data or protocol deviations, 512 women will be enrolled.

STATISTICAL ANALYSIS

Continuous variables will be summarized as mean (standard deviation) or median (interquartile range) and compared with the t-test or Mann-Whitney U test; categorical variables will be compared with the chi-square or Fisher's exact test. Multivariable logistic regression will estimate the association of FOC with intrapartum cesarean delivery and with epidural request, reported as adjusted odds ratios with 95% confidence intervals. Linear regression will be used for VAS scores and for cervical dilatation at epidural request. The ability of the W-DEQ-A score to discriminate women who undergo intrapartum cesarean delivery will be explored with receiver operating characteristic (ROC) analysis. A two-sided p value below 0.05 will be considered statistically significant.

ETHICS AND DATA PROTECTION

The study will start only after approval by the Ankara Bilkent City Hospital Medical Research Scientific and Ethical Evaluation Board (TABED). Written informed consent will be obtained from all participants, who may withdraw at any time without any effect on their care. The study will be conducted in accordance with the Declaration of Helsinki (2024 revision) and Good Clinical Practice, and personal data will be processed in line with the Turkish Personal Data Protection Law (KVKK, Law No. 6698).

研究の種類

観察的

入学 (推定)

300

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

研究場所

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

18年~45年 (大人)

健康ボランティアの受け入れ

いいえ

受講資格のある性別

女性

サンプリング方法

非確率サンプル

調査対象母集団

Nulliparous women aged 18 to 45 years with a singleton, cephalic, term pregnancy (37+0 to 41+6 weeks) who are admitted to the labor and delivery unit of Ankara Bilkent City Hospital, a tertiary referral center in Ankara, Türkiye, for planned vaginal birth, either in the latent phase of spontaneous labor or for induction of labor. Eligible women will be invited consecutively during the recruitment period.

説明

Inclusion Criteria:

  • Nulliparous women (no previous birth at 20 weeks of gestation or later)
  • Age 18 to 45 years
  • Singleton pregnancy in cephalic presentation
  • Term gestation of 37+0 to 41+6 weeks, dated by first-trimester ultrasound or a reliable last menstrual period
  • Admission to the labor and delivery unit for planned vaginal birth, either in the latent phase of spontaneous labor (cervical dilatation less than 5 cm) or for induction of labor
  • Able to read and understand Turkish
  • Written informed consent

Exclusion Criteria:

  • Planned cesarean delivery or a contraindication to vaginal birth (for example placenta previa or previous uterine surgery entering the uterine cavity)
  • Cervical dilatation of 5 cm or more at enrollment
  • Any analgesic given for labor pain before the questionnaire is completed
  • Contraindication to neuraxial (epidural) analgesia, such as coagulopathy, significant thrombocytopenia or infection at the puncture site
  • Known major fetal anomaly or intrauterine fetal death
  • Severe maternal disease likely to change labor or analgesia management, such as preeclampsia with severe features or significant heart disease
  • Psychiatric disorder requiring medication, or current use of psychotropic drugs
  • Inability to complete the questionnaire, for example because of cognitive impairment or a language barrier

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 観測モデル:COHORT
  • 時間の展望:PROSPECTIVE

コホートと介入

グループ/コホート
介入・治療
Severe Fear of Childbirth (W-DEQ-A Score 85 or Higher)

Nulliparous women with a term singleton pregnancy planning vaginal birth whose W-DEQ-A total score at enrollment is 85 or higher, indicating severe fear of childbirth. Participants receive routine labor care; no intervention is assigned by the investigators.

Self-administered Turkish version of the W-DEQ-A: 33 items rated on a 6-point Likert scale (total score 0-165; higher scores indicate greater fear of childbirth), completed once at enrollment before active labor and before any analgesia. It is used only to measure fear of childbirth and does not change clinical care.

Non-severe Fear of Childbirth (W-DEQ-A Score Below 85)

Nulliparous women with a term singleton pregnancy planning vaginal birth whose W-DEQ-A total score at enrollment is below 85. Participants receive routine labor care; no intervention is assigned by the investigators.

Self-administered Turkish version of the W-DEQ-A: 33 items rated on a 6-point Likert scale (total score 0-165; higher scores indicate greater fear of childbirth), completed once at enrollment before active labor and before any analgesia. It is used only to measure fear of childbirth and does not change clinical care.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Rate of Intrapartum (Unplanned) Cesarean Delivery
時間枠:From enrollment to delivery during the same hospital admission (up to 7 days)

Percentage of participants delivered by intrapartum (unplanned) cesarean section, compared between participants with a W-DEQ-A score of 85 or higher and those with a score below 85. The W-DEQ-A total score ranges from 0 to 165, with higher scores indicating greater fear of childbirth; the association with the continuous score will also be assessed.

From enrollment to delivery during the same hospital admission (up to 7 days)

二次結果の測定

結果測定
メジャーの説明
時間枠
Mode of Delivery
時間枠:At delivery (up to 7 days after enrollment)

Number and percentage of participants with spontaneous vaginal delivery, operative vaginal delivery (vacuum or forceps) and intrapartum cesarean delivery, compared between the two W-DEQ-A groups.

At delivery (up to 7 days after enrollment)
Rate of Epidural Analgesia Request
時間枠:From enrollment to delivery (up to 7 days)

Percentage of participants who request epidural analgesia during labor, as documented by the attending midwife or physician, regardless of whether the epidural is placed.

From enrollment to delivery (up to 7 days)
Cervical Dilatation at the Time of Epidural Request
時間枠:At the time of epidural request (during labor)

Cervical dilatation in centimeters (0-10 cm) at the vaginal examination performed at the time of the epidural request, among participants who request epidural analgesia. Lower values indicate an earlier request in labor.

At the time of epidural request (during labor)
Labor Pain Intensity in Active Labor
時間枠:At the first vaginal examination showing cervical dilatation of 5 cm or more (active phase of labor)

Pain intensity measured with a 10-cm visual analogue scale (VAS; 0 = no pain, 10 = worst imaginable pain; higher scores indicate more pain) at the first vaginal examination showing cervical dilatation of 5 cm or more, before any analgesia.

At the first vaginal examination showing cervical dilatation of 5 cm or more (active phase of labor)

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

捜査官

  • 主任研究者:AYŞENUR TÜRE、ANKARA BİLKENT CİTY HOSPİTAL

出版物と役立つリンク

研究に関する情報を入力する責任者は、自発的にこれらの出版物を提供します。これらは、研究に関連するあらゆるものに関するものである可能性があります。

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2026年10月1日

一次修了 (推定)

2026年12月31日

研究の完了 (推定)

2027年1月31日

試験登録日

最初に提出

2026年11月12日

QC基準を満たした最初の提出物

2026年11月12日

最初の投稿 (実際)

2026年11月18日

学習記録の更新

投稿された最後の更新 (実際)

2026年11月18日

QC基準を満たした最後の更新が送信されました

2026年11月12日

最終確認日

2026年11月1日

詳しくは

本研究に関する用語

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

いいえ

IPD プランの説明

Individual participant data will not be shared, in accordance with the Turkish Personal Data Protection Law (KVKK, Law No. 6698), the informed consent obtained from participants and the institutional data-use commitment of Ankara Bilkent City Hospital. Aggregated results will be published in a peer-reviewed journal.

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する